Revlon Donates $1 Million To Cancer Research

Revlon has made a $1 million donation to the Revlon/UCLA Women’s Cancer Research Program. The donation was unveiled by Revlon chairman Ronald O. Perelman, CEO Lorenzo Delpani, and global brand ambassador Halle Berry the LOVE IS ON celebratory luncheon in Los Angeles earlier this week.

The luncheon honored Dr. Dennis J. Slamon, M.D., Ph.D., and director of the Revlon/UCLA Women’s Cancer Research Program at UCLA’s Jonsson Comprehensive Cancer Center, for his outstanding achievements in cancer research.

The effort is the first phase of Revlon’s new philanthropic platform of bigger and more impactful donations to women’s health initiatives that is in keeping with Revlon’s LOVE IS ON global mission to inspire love, according to the firm.

 “LOVE IS ON is in everything we do at Revlon, including our commitment to caring for women’s health,” said Lorenzo Delpani, CEO of Revlon, Inc. “It is LOVE that inspired our philanthropic direction to make more significant and impactful donations to women’s health initiatives. We unveiled the first phase of this mission with a direct donation of $1 million to Dr. Dennis Slamon and the Revlon/UCLA Women’s Cancer Research Program. It is our goal that this donation will help to enable Dr. Slamon and his team to continue their research into major cancer breakthroughs that will lead to lives being saved, ultimately finding a cure.”

Revlon’s relationship with Dr. Slamon began in 1990.

“Over 20 years ago, we made the decision to fund research that promised to change the face of breast cancer treatment forever. Some said it was a risk,” said Perelman, “but one that has proven very successful. As we know today, Herceptin has become one of the most important drugs in treating certain types of breast cancer and has turned one of the deadliest forms of the disease into one of the most treatable. Revlon is committed to continuing the fight against all cancers and to doing so alongside Dr. Slamon.”

Since 1990, Ronald Perelman and Revlon, through collaboration with the Entertainment Industry Foundation and Lilly Tartikoff, have distributed $49 million to the Revlon/UCLA Women’s Cancer Research Program and Dr. Dennis J. Slamon. These funds have helped accelerate critical research needed to bring cancer treatment drugs such as Herceptin and Ibrance to market. Moving forward, Revlon will be unveiling a new campaign later this year to raise awareness and funds in support of other noteworthy women’s health initiatives.

“The goal of our new philanthropy effort is to provide funding at a level that will truly make a difference in women’s lives,” added Lorenzo Delpani, CEO of Revlon, Inc. “We are confident that this new path will continue to have a significant impact on women’s health initiatives.”